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Abstract
Background: With increasing numbers of dental implants placed annually, complications such as peri-implantitis
and the subsequent periprosthetic osteolysis are becoming a major concern. Implantoplasty, a commonly used
treatment of peri-implantitis, aims to remove plaque from exposed implants and reduce future microbial adhesion
and colonisation by mechanically modifying the implant surface topography, delaying re-infection/colonisation of
the site. This in vitro study aims to investigate the release of particles from dental implants and their effects on
human gingival fibroblasts (HGFs), following an in vitro mock implantoplasty procedure with a diamond burr.
Materials and methods: Commercially available implants made from grade 4 (commercially pure, CP) titanium
(G4) and grade 5 Ti-6Al-4 V titanium (G5) alloy implants were investigated. Implant particle compositions were
quantified by inductively coupled plasma optical emission spectrometer (ICP-OES) following acid digestion. HGFs
were cultured in presence of implant particles, and viability was determined using a metabolic activity assay.
Results: Microparticles and nanoparticles were released from both G4 and G5 implants following the mock
implantoplasty procedure. A small amount of vanadium ions were released from G5 particles following immersion
in both simulated body fluid and cell culture medium, resulting in significantly reduced viability of HGFs after 10
days of culture.
Conclusion: There is a need for careful evaluation of the materials used in dental implants and the potential risks
of the individual constituents of any alloy. The potential cytotoxicity of G5 titanium alloy particles should be
considered when choosing a device for dental implants. Additionally, regardless of implant material, the
implantoplasty procedure can release nanometre-sized particles, the full systemic effect of which is not fully
understood. As such, authors do not recommend implantoplasty for the treatment of peri-implantitis.
Keywords: Gingival, Fibroblast, Dental implants, Peri-implantitis, Implantoplasty, Titanium, Titanium alloy, Vanadium,
Toxicity
Background
Dental implants offer a viable long-term treatment
option for patients with missing teeth [1, 2]. The use of
metallic dental implants has relatively high reliability
and long-term success rates; however, it is not without
complications and the need for ongoing maintenance
persists. Particles are generated during the life span of
an implant, and this can have significant physiological
implications such as disrupted osseointegration and
bone resorption (osteolysis) that may in turn lead to im-
plant loss [3, 4]. Particles can be released during implant
bed preparation, from implant surface due to shear
forces during fixture insertion, from implant-abutment
interface due to wear and during functional loading [5,
6]. Exposure to the oral environment such as saliva, bac-
teria and chemicals such as fluoride can further facilitate
the corrosion and degradation of titanium [7–9]. A wide
range of 10 to 20 μm in sizes of the released particles
were reported in several locations such as at implant
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surface and peri-implant bone as well as distant sites
such as the lungs, liver and kidney [5].
One common issue that can have detrimental impact
on the long-term outcome of implant restorations and
cause implant failure is peri-implantitis [10]. Peri-
implantitis is a plaque-associated pathological condition
occurring in tissues around dental implants [11]. It is
characterised by inflammation in the peri-implant
mucosa and subsequent progressive loss of surrounding
supporting bone in which the implant is anchored. The
risk of peri-implantitis is dependent on several of factors,
and the frequency of peri-implantitis diagnosis has been
reported to be 1–47% with selected implant systems
[12, 13]. The large variation is due to the criteria used
in diagnosis of peri-implantitis, e.g. some diagnose
peri-implantitis with 0.5 mm crestal bone loss while at
the other extreme 4 mm bone loss is needed for the
diagnosis. Moderate to severe peri-implantitis (signs
include bleeding on probing/suppuration and bone loss
greater than 2 mm) was reported in 14.5% of patients
[14]. Recently, the 2017 World Workshop Consensus
report stated that in the absence of previous examin-
ation that records a diagnosis of peri-implantitis can
be made with probing depths of greater than 6 mm
and crestal bone loss greater than 3 mm in the pres-
ence of bleeding and/or suppuration on gentle probing.
However, if previous records are available, then the
diagnosis can be made with any increase in pocket
depth with post remodelling bone loss of greater than
0.5 mm in the presence of bleeding and/or suppuration
on gentle probing [11], A number of studies suggested
this inflammatory disease is associated with anaerobic
plaque bacteria [15, 16]. It has also been suggested
peri-implantitis can also be related to inadequate
distribution of the chewing pressure on the tissues
surrounding the implant, leading to the loosening of
the artificial supports [17]. While plaque is the main
risk factor, patients who have history of periodontal
disease prior to implant treatment, and those with
other risk factors such as poor oral hygiene, smoking
or uncontrolled diabetes, also experienced higher rates
of peri-implant disease [18, 19]. Additionally, there are
also suggestions that peri-implantitis is the result of
foreign body reaction [20].
Common treatment options for peri-implantitis in-
clude mechanical debridement (with or without antisep-
tic application) administration of local and systemic
antibiotics or surgical techniques. It is well accepted that
altering the affected implant surface is necessary to
minimise the establishment of biofilm. Implantoplasty
involves mechanically modifying the implanted threads
(and the rough surface) that have become exposed in the
patient’s mouth, due to bone resorption, by removing
the outer surface of the metal with rotary instruments,
in situ. The purpose is to reduce the roughness of the sur-
face, and it is a commonly used technique to reduce plaque
retention and prevent re-infection of the site [21, 22].
To the best of our knowledge, the release of particles
from implants following implantoplasty procedure and
their effect on cells has not been investigated. The
purpose of this in vitro study was to assess the size,
composition, ionic product release and biological impact
of particles released from commonly used commercially
pure grade 4 titanium and grade 5 titanium alloy implants
following an implantoplasty procedure with diamond burr.
This aims to raise the awareness of potential detrimental
side effects of implantoplasty and the need for careful
consideration of dental implant material.
Materials and methods
Materials
Reagents and solvents were purchased from Sigma-Aldrich
(Dorset UK). Commercially pure grade 4 titanium implants
(n = 3) were purchased from Straumann (Sussex UK,
Model number 021.4512, bone-level implant diameter 4.1
mm, Regular CrossFit®, SLA® 12mm Roxolid®) (Fig. 1a).
Grade 5 Ti-6Al-4 V titanium alloy implants were purchased
from Biohorizons (Berkshire UK, n = 3, model number
PBR50105, RBT 5.0 × 10.5mm, 5.7 Platform) (Fig. 1d).
The methods in this study follow SPQR (standards for
reporting qualitative research) guidelines.
Mock implantoplasty protocol
Implants were secured with forceps held using table
clamps. In order to minimise variations in the pressure
applied during the implantoplasty, all procedures were
completed by one operator. A handpiece (W&H, Alegra
dental turbine handpieces TE-98 Led G) was used with
motor set at 50,000 rpm. Diamond burrs (Diatech
G856.314.021.9ML-200453AA) were limited to single
use for 5 min on each implant. Particles released from
implants following implantoplasty were collected,
weighed and analysed for size, composition and ion re-
lease characteristics.
Dynamic light scattering
Dynamic light scattering (DLS) was performed using a
Malvern Zetasizer (instrument 2000) instrument to deter-
mine the size distribution of released implant particles. The
instrument is equipped with a HeNe laser (λ = 632.8 nm)
with a backscattering detection angle of 173°. Particle size
was also measured using Malvern Mastersizer (Malvern
Panalytical Ltd, Royston, UK). Measurement duration (15
min) and number of sub-runs (3) were automatically
adjusted by the instrument. Particles were suspended in
70% ethanol at a concentration of 5mgml−1 and sonicated
for 15min prior to each measurement.
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Scanning electron microscopy
Particle samples were dried in a 60 °C oven and secured
to an aluminium sample holder with carbon tape and
coated with 10 nm gold. Images were acquired using
Zeiss Sigma-300 scanning electron microscope (SEM).
For energy dispersive x-ray spectroscopy (EDX) analysis,
samples were secured with silver conductive paint.
Ion release from titanium particles
Simulated body fluid (SBF) was chosen as the dissolution
test solution as we were interested in what happens
when the particles become embedded in the soft/hard
tissue rather than their interaction with saliva. SBF was
prepared using the Kokubo method [23, 24]. Seven hun-
dred millilitres of deionised (DI) water in a 1-L polypro-
pylene beaker was warmed to 37 °C in a water bath. The
reagents were slowly added to the DI water in the order
given in [25], while the solution was continuously
stirred. The pH was continuously monitored to avoid
precipitation due to sudden increase. Once the reagents
were mixed, the SBF was filled to 1 L with DI water. SBF
was stored at 37 °C and used within 2 days. The pH was
adjusted to 7.4 before use at 37 °C.
Grade 4 and 5 titanium (Ti) particles were suspended
in SBF at concentrations of 0.75, 1.5 and 3mgml−1 in
airtight polyethylene containers, which were placed on
an orbital shaker rotating at 120 rpm inside a 37 °C
incubator. One millilitre of aliquots was taken at day 0,
3 and 10 for the analysis of pH and ionic concentration.
Cell culture and viability assay
Human gingival fibroblasts (HGFs) (PCS-201-018TM,
ATCC®, UK) were culture expanded in basal Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with
100 unit ml−1 penicillin, 100 μg ml−1 streptomycin and
10% (v/v) foetal bovine serum (FBS) in standard tissue-
culture flasks in a humidified atmosphere containing 5%
CO2. Upon confluence, cells were subcultured using 1×
trypsin-EDTA (500 μg ml−1 trypsin with 200 μg ml−1
EDTA in Hank’s Balanced Salt Solution).
To evaluate the potential cytotoxic effect of grade 4
and 5 Ti particles on HGFs, two groups of test samples
were prepared for cell culture, the particles in media and
the dissolution products of the particles. Ti particles
were sterilised with 70% ethanol for 1 min before use.
Group 1 (dissolution): grade 4 and 5 Ti particles were
suspended in DMEM at concentrations of 0.75, 1.5 and
3mgml−1 in airtight polyethylene containers, which
were placed on an orbital shaker rotating at 120 rpm. in-
side a 37 °C incubator for 72 h. The media were filtered
through 0.2 μm PTFE membrane syringe filters following
incubation to remove the particles before use in cell cul-
ture. Group 2 (particle): Sterilised grade 4 and 5 Ti parti-
cles were suspended in DMEM at concentrations of
Fig. 1 Representative photo of implants and SEM images of particles produced by mock implantoplasty procedure. a–c Straumann 021.4512,
bone level, diameter 4.1 mm, regular CrossFit®, SLA® 12mm Roxolid® (commercially pure grade 4 titanium). d–f Biohorizons PBR 50105, RBT 5.0 ×
10.5 mm, 5.7 Platform (grade 5 titanium alloy). Arrows indicate titanium oxide spheres. Scale bar represents 20 and 5 μm for low and high
magnification respectively
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0.75, 1.5 and 3mgml−1 and used for cell culture without
filtering. Basal DMEM and DMEM containing unpro-
cessed grade 4 and 5 implants were used as controls.
One millilitre of aliquots was taken at day 0, 3 and 10
for the analysis of pH and ionic concentration.
A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) metabolic activity assay was performed
to assess cellular metabolic activity of HGFs in response
to group 1 and 2 test samples. Briefly, HGFs were seeded
at 3000 cells cm−2 in 24-well plates and allowed to grow
for 24 h in basal DMEM. Basal medium was then re-
placed with the test samples supplemented with 10%
FBS and cultured for a further 3, 7 or 10 days. At each
time point, culture medium was replaced with 1 mgml−1
MTT in plain DMEM. MTT solution was removed after
3 h, and dimethyl sulfoxide (DMSO) was added to dis-
solve the formazan crystals formed by living cells. The
luminescence of the resulting solutions was measured at
570 nm in a plate reader.
Inductively coupled plasma optical emission spectrometer
(ICP-OES)
The elemental concentration of titanium, aluminium,
iron and vanadium in the following media was deter-
mined using ICP-OES (iCaP6300 Duo, Thermo Fisher
Scientific, UK) (1) SBF; (2) dissolution products of the
particles from immersion in DMEM for 3 days (dissol-
ution), and (3) DMEM sampled during the cell culture
studies where cells were cultured with the particles (par-
ticle). Mixed standards of titanium, aluminium, iron and
vanadium ions were prepared at 0, 2, 5, 20 and 40 ppm
for calibration. All samples were run in triplicates, and
an acid blank was incubated under the same conditions
and used as a control.
Statistical analysis
Results were presented as mean ± standard deviation
(S.D.). Mann–Whitney U test (2 groups) or Mann–
Whitney U test with Bonferroni correction (> 2 groups)
was performed using OriginPro 2019. Results were
deemed significant if the probability of occurrence by
random chance alone was less than 5% (i.e. p < 0.05).
Results
Particles released from implants following the mock
implantoplasty procedure were collected, and micropar-
ticle size of particles produced from the grade 4 (G4)
and grade 5 (G5) implants was 77.4 ± 9.1 μm (modal
number 66.3 μm) and 48.4 ± 6.4 μm respectively (modal
number 43.1 μm). DLS analysis showed nano-sized parti-
cles were also present: hydrodynamic diameters were
125.4 ± 10.9 nm (modal number 109.3 nm) and 57.74 ±
2.66 nm (modal number 52.1 nm) respectively. SEM im-
ages (Fig. 1) revealed that particles fragmented from
both G4 and G5 implants as the result of implantoplasty
were irregular in shape and varied significantly in sizes.
The elemental composition of the particles was analysed
using EDX (Fig. 2). The EDX spectra demonstrated
distinctive differences between G4 and G5 particles. In
addition to titanium (Ti), both aluminium (Al) and van-
adium (V) were detected in G5 particles. Carbon (C) was
detected in both samples. According to EDX analysis,
the spherical objects amongst implant particles (indi-
cated by arrows in Fig. 1) were titanium oxide.
Release of ions from the G4 and G5 particles was first
investigated in SBF (Fig. 3). Upon immersion, the release
of Ti was minimal from both G4 and G5 particles in
SBF. Release of V from G5 particles was detected by ICP
only after 10 days of immersion. There was no noticeable
release of aluminium (Al) and iron (Fe) ions. The pH of
SBF remained at 7.4 during the immersion period. Simi-
lar results were observed when the particles were
immersed in DMEM (Fig. 4), with low release of Ti and
no noticeable release of aluminium Al and Fe from both
G4 and G5 particles. V, up to 0.116 ± 0.023 ppm, was
only detected in medium containing G5 implant parti-
cles. Changing the concentration of the particles had
little effect. As Al results were negligible, we assumed
that no alloy particles passed through the 200-nm filters,
but TiO2 nanoparticles may have contributed to the Ti
values (DLS measurement of blank media control
returned value of 0).
The effect of G4 and G5 particles and their dissolution
products on human gingival fibroblast viability in vitro
was investigated using an MTT metabolic activity assay
(Fig. 5). Administration of the dissolution products had
no effect on cellular metabolic activity up to day seven,
but there appeared to be a reduction in metabolic activ-
ity in cells exposed to G5 dissolution products by day
10, though it was not statistically significant. When the
cells were exposed to G5 particles, metabolic activity sig-
nificantly reduced as early as day 3. However, when cells
were cultured with the G4 particles, there were no ad-
verse effects. The significantly reduced metabolic activity
as a result of exposure to G5 particles was observed at
all-time points. Changing the concentration of the parti-
cles had little effect.
Discussion
Unalloyed titanium, often referred to as commercially
pure grade 4 titanium (CpTi), usually contains some
trace elements of carbon, oxygen, nitrogen and iron
(American Society for Testing and Materials inter-
national standards). These trace elements improve the
mechanical properties of CpTi and are found in higher
amounts from grade 1 to 4 CpTi [26]. Many dental im-
plants are made from grade 4 (G4) CpTi, in order to im-
prove its fatigue strength, and companies have also used
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grade 5 (G5) titanium alloys (Ti-6Al-4 V), which con-
tains metals including vanadium and aluminum.
In the present study, standardised implantoplasty pro-
cedure was performed on both G4 (Straumann, model
number 021.4512, bone-level implant diameter 4.1 mm,
Regular CrossFit®, SLA® 12mm Roxolid®) and G5 (Bio-
horizons, model number PBR50105, RBT 5.0 × 12mm,
5.7 Platform) implants. Implant particles were released
from both types of implants (Fig. 1). The smaller particle
size generated from G5 implants is likely to be due to
the G5 alloy having a higher hardness. Typical G5 alloy
has a hardness of 36 (HRC, Rockwell C) compared to 23
(HRC, Rockwell C) of G4 [27, 28]. Some TiO2 spheres
were detected. This is because when titanium implant
surface is exposed to air, titanium oxide (TiO2) film is
formed on the implant surface. This layer (1.5–10 nm
thickness) is formed due to the high affinity of Ti for
oxygen [29]. This in turn could contribute to a certain
Fig. 3 Titanium (Ti) and vanadium (V) release from the particles in simulated body fluid (SBF). Experimental duration was 10 days. Results
presented as mean ± standard deviation, n = 3
Fig. 2 EDX spectra of particles produced by the mock implantoplasty procedure (SEM images in Fig. 1). a, b Particles from grade 4 commercially
pure titanium implant, a angular microparticles and b small spheres. c, d particles from grade 5 titanium alloy, c angular microparticles and d
small spheres (grade 5)
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degree of resistance to corrosion of titanium implants
[30, 31]. G5 implant particles contain vanadium (Fig. 2),
and vanadium ions were released into simulated body
fluid and DMEM following 10 days immersion (Fig. 3
and 4).
HGFs exposed to dissolution products of G4 and G5
implant particles did not experience reduction in viabil-
ity (Fig. 5). This is due to no detectable vanadium release
in DMEM by G5 particles during the preparation of the
dissolution media, which was 3 days soaking in DMEM
(Fig. 4a, b). There was no distinct difference in the
amount of titanium ions released from G4 and G5 parti-
cles. Direct exposure to G5 implant particles in culture
did result in significantly reduced cell viability at all-time
points, from 3 to 10 days of culture, while G4 implant
particles demonstrated no adverse effect on cell viability
(Fig. 5b). The cytotoxic effects of vanadium are well doc-
umented [32, 33], so the further relative reduction in cell
viability, compared to control and G4 particles, from 10
days was thought to be due to continued release of V
during the culture (there was no distinct difference in
the amount of titanium ions released from G4 and G5
particles). The delayed release of the V agrees with cor-
rosion studies on Ti-6Al-4 V alloys, which reported
time-dependent corrosion [31, 34].
There have been suggestions that sufficient irrigation
around the implant and suction of metallic debris during
surgical procedures, such as implantoplasty, might re-
duce the deposition of metallic particles and ions into
surrounding tissue [35]. However, there is no scientific
evidence that such measures can fully remove implanto-
plasty debris from the surround environment, and these
procedures can also disseminate bacteria into the sur-
rounding tissues [5, 36]. Previous studies indicated that
the cytotoxicity of vanadium ion is dose dependent,
where concentrations of 23–30 μM (1.17–1.53 μg ml−1)
significantly reduced cell viability in NIH3T3 fibroblasts
[33, 37]. Herein, the V concentration was approximately
0.1 μg ml−1 after 10 days of exposure to DMEM, which
does explain the significant reduction in viability of
HGFs.
Previous studies suggested the viability of calvarial rat
osteoblasts in direct contact with G4 CpTi particles (un-
specified grade, particle diameter 3.1 ± 3.6 μm) with a
concentration higher than 1.5 mgml−1 decreased signifi-
cantly due to rapid phagocytic process [38]. In the
present study, the viability of HGFs appeared to be not
affected by G4 CpTi implant particles, even at high
concentrations (3 mgml−1). This is due to the lack of
vanadium and possibly larger particle size. Here, G5 par-
ticles are. Although a range of particle size of G5 was
measured in this study, a portion of the particles gener-
ated from the mock implatoplasty process in the current
study is comparable to that reported by Pioletti et al.
[38]. The internalisation of G5 particles, especially sub-
micron particles, and the subsequent local release of
Vanadium ions inside the cytoplasm could increase the
toxicity of the particles. A change in pH of culture
Fig. 4 Titanium (Ti) and vanadium (V) content in Dulbecco’s Modified Eagle Medium (DMEM). a, b Dissolution products (media filtered through
0.2 μm PTFE membrane following initial soaking of the particles for 3 days) and c, d DMEM sampled during cell culture studies where cells were
cultured with the particles over a period of 10 days (particles removed prior to ICP measurement). Results presented as mean ± standard
deviation, n = 3
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medium was not responsible for the reduced viability as
the value of pH was found affect by neither G4 nor G5
implant particles.
As discovered by Malvern Mastersizer and DLS, the
sizes of G4 and G5 implant particles released as re-
sult of implantoplasty are in the range of nano (NPs)
and fine particles (FPs) (125.4 ± 10.9 nm–77.4 ±
9.1 μm and 57.74 ± 2.66 nm–48.4 ± 6.4 μm for G4
and G5 implant particles, respectively). NPs and FPs
can enter cells via a number of routes such as phago-
cytosis, endocytosis and macropinocytosis as well as
passive diffusion [39]. Exposure to nanomaterials and
nanoparticles can potentially result in biological re-
sponses at molecular level such as DNA methylation,
Fig. 5 The effect of grade 4 and grade 5 implant particles on human gingival fibroblast viability in vitro. Viability was determined using an MTT
metabolic activity assay. Cells were exposed to either a dissolution products (ions and nanoparticles) or b culture medium containing suspended
implant particles throughout the duration of the culture period. Cells were exposed to various concentrations of particles (0.75, 1.5 or 3 mgml−1).
Basal medium and basal medium containing unprocessed dental implants were used as controls. All results were normalized against the value of
basal medium at day 3. Results presented as mean ± standard deviation, n = 3. The asterisk indicates p < 0.05, and + indicates 0.05 < p < 0.1
when compared to basal medium control at each time point
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histone post-translational modifications and noncod-
ing RNAs in mammalian cells [40, 41].
In the field of Orthopaedics, titanium (oxide) wear
particles from implants were reported to enter bone-
forming cells and stem cells via endocytosis and cause
adverse biological response including osteolysis [42–45].
It has also been proposed that titanium particles induce
secretion of pro-inflammatory cytokines by fibroblasts,
which are involved in the chemotactic migration and re-
cruitment of monocytes/macrophage and subsequently
the pathogenesis of aseptic loosening of implants [46].
Therefore, although no short-term effect of G4 particles
on HGFs was observed in the present study, further,
long-term investigations are also of crucial importance.
Further, the effect of implant particles on other cell
types within the oral and systemic environments should
not be overlooked. Although the health hazards of FPs
and NPs are relatively less well established, literature in
the fields of toxicology does indicate a glimpse of pos-
sible toxicity that should compel clinicians to carefully
weigh the possible adverse human health effects. Lastly,
“impurities” have been reported in titanium based im-
plant materials, for example, up to 0.5 wt% iron (Fe) in
commercial pure titanium (grade 1, 2 and 4) and 0.013
wt% nickel (Ni) (grade 1 and 2) [36, 47, 48]. While these
trace metals may not present health risk in a whole im-
plant, ions and particles released as a result of corrosion
and/or mechanical intervention such as implantoplasty
have been reported to cause adverse allergic reactions in
humans [49, 50]. There is no current consensus agree-
ment on the risk of particles released from Ti; however,
it would be prudent for clinicians to carefully evaluate
the materials used and to consider the potential risks of
the individual constituents of any alloy, as indicated in
this study.
Conclusion
In the present study, the release of nano and fine
particles from both commercially pure grade 4 titanium
and grade 5 Ti-6Al-4 V alloy implants following implan-
toplasty procedure was reported. Exposure to grade 5
implant particles resulted in significantly reduced cell
viability compared to exposure to grade 4 particles. One
of the major challenges facing implant dentistry is the
lack of information on the possible adverse health effects
caused by the exposure to these nano-sized particles.
Authors acknowledge that it is inaccurate to directly ex-
trapolate the current findings into human subjects in
clinical settings. However, it is probable that the poten-
tial toxicity of Ti-6Al-4 V and/or fine implant particles
in vivo are also due, at least in part, to the same mech-
anism presented in the current study. For patient safety,
the potential cytotoxicity of Ti-6Al-4 V alloy particles
must be considered when used as a material for dental
implants. Furthermore, regardless of implant material, the
implantoplasty procedure can release nano-sized particles,
the full systemic effect of which is not fully understood.
Particles have been shown to have local toxic effects;
therefore, the authors do not recommend implantoplasty
as a safe procedure for the treatment of peri-implantitis.
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